logo
Select company
Select metric
$ 95.8MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
8
Sector
12
Industry
16
History
22
$ 3.74Close
$ 0.43 - $ 3.74 52-Week Range
Ticker Information

Ticker

CTMX

Company Name

CYTOMX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CYTOMX THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CTMX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 95.8M
3/31/2025$ 7.35M
12/31/2024$ 7.52M
9/30/2024$ 5.52M
6/30/2024$ 35.19M
3/31/2024$ 30.4M
12/31/2023$ 30.23M
9/30/2023$ 30.18M
6/30/2023$ 507K
3/31/2023$ 641K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 4.27M.
  • Over the past 5 years, CYTOMX THERAPEUTICS INC's average CF - Equity has been $ 37.39M.
  • The median CF - Equity for CYTOMX THERAPEUTICS INC during this period was $ 12.21M
  • CYTOMX THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 123.47M.
  • The lowest CF - Equity recorded by CYTOMX THERAPEUTICS INC in the same timeframe $ 507K

CYTOMX THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 1.3MRGNX : REGENXBIO INC $ 884KHRTX : HERON THERAPEUTICS INC $ 1.28MADCT : ADC THERAPEUTICS SA $ 42.71MGLUE : MONTE ROSA THERAPEUTICS INC $ 1MYMAB : Y-MABS THERAPEUTICS INC $ 2.41MXNCR : XENCOR INC $ 210.01MNRC : NATIONAL RESEARCH CORP $ -26.72MSPOK : SPOK HOLDINGS INC $ -2.56MVNDA : VANDA PHARMACEUTICALS INC $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

CTMX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 507K

Minimum

Jun 30, 2023

$ 123.47M

Maximum

Mar 31, 2021

$ 37.39M

Average

$ 12.21M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 139.46K with a standard deviation of $ 17.67M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 139.46K
median$ 0
std$ 17.67M